Marcela Banegas

ORCID: 0000-0003-2604-1348
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Celiac Disease Research and Management
  • CAR-T cell therapy research
  • Microscopic Colitis
  • Hip and Femur Fractures
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Autoimmune and Inflammatory Disorders Research
  • Biomedical Ethics and Regulation
  • Clostridium difficile and Clostridium perfringens research
  • Inflammatory Bowel Disease
  • Gastrointestinal motility and disorders
  • Pelvic and Acetabular Injuries
  • Garlic and Onion Studies
  • Gastrointestinal disorders and treatments
  • Cancer Genomics and Diagnostics
  • Hip disorders and treatments
  • Bariatric Surgery and Outcomes
  • Nutrition, Genetics, and Disease
  • Biliary and Gastrointestinal Fistulas
  • Palliative Care and End-of-Life Issues
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV/AIDS drug development and treatment
  • Pediatric health and respiratory diseases
  • Virus-based gene therapy research
  • Eosinophilic Esophagitis

Beth Israel Deaconess Medical Center
2023-2025

Harvard University
2023-2025

Boston Children's Hospital
2021-2025

Johns Hopkins University
2023-2024

Deaconess Hospital
2021

Boston Children's Museum
2021

Hospital Vega Baja
2019

Clostridioides difficile infection (CDI) immune response is influenced by the innate and adaptive (humoral) systems. Our prior research found attenuated humoral responses to C in immunocompromised hosts (ICHs) with CDI. We sought evaluate whether CDI was ICH status. conducted a prospective study of hospitalized adults (acute diarrhea, positive stool nucleic acid amplification testing [NAAT], decision treat), without immunosuppression measured panel cytokines (granulocyte colony-stimulating...

10.1093/ofid/ofad090 article EN cc-by-nc-nd Open Forum Infectious Diseases 2023-02-18

Introduction We investigated the frequency of personal involvement with celiac disease (CeD) among CeD researchers and their motive to pursue research, compared in inflammatory bowel (IBD) or type 1 diabetes (T1D) research. Methods An online survey was sent CeD, IBD T1D researchers. Results 42% had an research interest, which similar (51%) significantly higher than respondents (27%, p<0.02). Discussion Personal is common may be beneficial when conducting patient-oriented

10.1101/2024.09.22.24314161 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-09-24

Obese habitus can lead to adverse outcomes for colorectal surgeries due technical challenges and pro-inflammatory immune mediators associated with excess adipose tissue. Surgical planning, pre-operative risk stratification, patient counseling of pediatric Crohn disease (CD) patients are limited by the scarcity data on this topic. We sought determine association between obesity hospital readmission in children CD undergoing intestinal resection.We used National Quality Improvement...

10.1097/mpg.0000000000003251 article EN Journal of Pediatric Gastroenterology and Nutrition 2021-07-27

e16279 Background: To date, few targetable mutations have been found to enhance PDAC treatment. Next-generation sequencing (NGS) of somatic mutation profiles may help tailor cytotoxic chemotherapy selection and guide translational research. Methods: We analyzed NGS data from a retrospective cohort 142 patients with unresectable biopsy-proven August 2009 December 2022. Individual were grouped into 14 distinct signaling pathways: cell cycle, DNA damage repair, KIT, ErbB2, TP53, MAPK-RAS, PIK3,...

10.1200/jco.2023.41.16_suppl.e16279 article EN Journal of Clinical Oncology 2023-06-01

243 Background: This study aimed to examine the effects of hospice enrollment timing on survival and end-of-life quality life indicators for pancreatic ductal adenocarcinoma (PDAC) patients. Methods: A retrospective chart review 152 patients with biopsy-proven PDAC from August 2009 December 2022 at a single center was conducted. Patients were categorized based timing: Early-Hospice (EH) (≥ 60 days before death), Late-hospice (LH) (< days), No Hospice (NH). Parameters assessed included...

10.1200/op.2023.19.11_suppl.243 article EN JCO Oncology Practice 2023-10-26
Coming Soon ...